Myomo Inc MYO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Myomo Reports Third Quarter 2026 Financial and Operating Results
Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference
Myomo to Report Third Quarter 2026 Financial Results on November 9
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Trading Information
- Previous Close Price
- $0.84
- Day Range
- $0.80–0.85
- 52-Week Range
- $0.61–1.89
- Bid/Ask
- $0.75 / $0.87
- Shares Outstanding
- 40.10M
- Market Cap
- $32.52M
- Volume/Avg
- 381,820 / 356,417
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 195
- Website
- https://www.myomo.com
Valuation
Metric | MYO |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 11.81 |
Price/Sales | 0.76 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | MYO |
|---|---|
Quick Ratio | 1.46 |
Current Ratio | 1.92 |
Interest Coverage | −5.27 |
Quick Ratio
MYO
Profitability
Metric | MYO |
|---|---|
Return on Assets (Normalized) | −29.82% |
Return on Equity (Normalized) | −122.14% |
Return on Invested Capital (Normalized) | −32.83% |
Return on Assets
MYO
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|&d!!n&% | LOCK|!V$d^ | $178B | |||
| Medtronic PLC MDT | LOCK|w@M>x! | LOCK|hWSq | $128B | |||
| Stryker Corp SYK | LOCK|qyK^#hYd | LOCK|s! | $118B | |||
| Boston Scientific Corp BSX | LOCK|&mLx?&g | LOCK|??bQL | $61B | |||
| Edwards Lifesciences Corp EW | LOCK|>g#$gmX< | LOCK|WH$# | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|dsk^!<! | LOCK|hnk | $36B | |||
| DexCom Inc DXCM | LOCK|#y#k!rX | LOCK|##Yhv | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|dM> | LOCK|@s | $28B | |||
| Steris PLC STE | LOCK|%##m%% | LOCK|@QfN | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|xsJ>xYQ% | LOCK|T!t | $19B |